πŸ‡ΊπŸ‡Έ FDA
Patent

US 9822057

Solid forms of treprostinil

granted A61KA61K31/192A61P

Quick answer

US patent 9822057 (Solid forms of treprostinil) held by United Therapeutics Corporation expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K31/192, A61P, A61P1/06, A61P1/18